Profile
K.
Reed Clark served as the Director of Gene Therapy Center at the Research Institute at Nationwide Children's Hospital from 2005 to 2014.
He also worked as a Professor at The Ohio State University.
Later, he served as the Head of Pharmaceutical Development at Dimension Therapeutics, Inc. from 2014 to 2017.
Dr. Clark received his undergraduate and doctorate degrees from The Ohio State University.
Former positions of K. Reed Clark
Companies | Position | End |
---|---|---|
DIMENSION THERAPEUTICS INC | Corporate Officer/Principal | 2017-10-31 |
Research Institute at Nationwide Childrens Hospital
Research Institute at Nationwide Childrens Hospital Miscellaneous Commercial ServicesCommercial Services Part of Nationwide Children's Hospital, Research Institute at Nationwide Children's Hospital is a social services organization based in Columbus, OH. The company's focus is not elsewhere classified research in the field of social services. | Corporate Officer/Principal | 2013-12-31 |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Training of K. Reed Clark
The Ohio State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Research Institute at Nationwide Childrens Hospital
Research Institute at Nationwide Childrens Hospital Miscellaneous Commercial ServicesCommercial Services Part of Nationwide Children's Hospital, Research Institute at Nationwide Children's Hospital is a social services organization based in Columbus, OH. The company's focus is not elsewhere classified research in the field of social services. | Commercial Services |
Dimension Therapeutics, Inc.
Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- K. Reed Clark